Potato tuber proteins efficiently inhibit human faecal proteolytic activity: implications for treatment of peri-anal

J G H Ruseler-van Embden1, L M C van Lieshout, S A Smits

  • 1University Medical Center Rotterdam, Rotterdam, the Netherlands. j.vanembden@erasmusmc.nl

Insights

Protease inhibitors found in potatoes can prevent and treat protease-induced perianal dermatitis. This study shows potato proteins significantly reduce fecal protease activity, offering a novel therapeutic approach for skin irritation.

Area of Science:

  • Gastroenterology
  • Dermatology
  • Biochemistry

Background:

  • Perianal dermatitis is a common complication of intestinal resections and infant fecal incontinence.
  • High concentrations of fecal pancreatic proteases are implicated as a causative agent.
  • Current treatments lack efficacy in addressing the underlying protease activity.

Purpose of the Study:

  • To investigate the potential of protease inhibitors for treating and preventing perianal dermatitis.
  • To assess the efficacy of inhibiting fecal proteases, the primary cause of inflammation.
  • To evaluate potato-derived protease inhibitors as a novel therapeutic strategy.

Main Methods:

  • Quantified proteolytic activity in fecal samples from patients and infants with perianal dermatitis.
  • Studied dermatitis development post-ileoanal anastomosis reservoir construction.
  • Assessed the in vitro and in vivo inhibitory effects of potato juice on fecal proteases.

Main Results:

  • Significantly elevated fecal protease activity observed in patients and infants compared to healthy adults.
  • 46 out of 48 patients developed protease-related dermatitis after ileum reservoir surgery.
  • Potato protein fractions effectively inhibited fecal proteases and prevented skin irritation in human volunteers.

Conclusions:

  • Potato proteins possess potent protease inhibitors that significantly reduce fecal proteolytic activity.
  • Topical application of these inhibitors presents a novel preventative strategy for protease-induced perianal dermatitis.
  • Further therapeutic studies are warranted to validate these promising findings.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
The Skin Microbiota01:27

The Skin Microbiota

The human skin serves as a complex ecosystem inhabited by a diverse community of microorganisms, including bacteria, fungi, and viruses. This microbiome plays a critical role in maintaining skin health and defending against pathogenic invaders. The composition of microbial communities varies significantly across different regions of the body, influenced primarily by the local levels of moisture and sebum.Regional Variation in Skin MicrobiotaCutibacterium acnes predominantly colonizes sebaceous...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...